Viruses

• Health & Medicine

England moves to a single-dose HPV vaccine

Children in England will need only one dose of the HPV vaccine to prevent cervical and other related cancers from September 2023. Children in England will need only one dose of the HPV vaccine to prevent cervical and other related cancers from September 2023.

21 June 2023

• Charity News

Cancer Research UK announces appointment of new Chair

Cancer Research UK has announced the appointment of Lord Simon Stevens as Chair of Council of Trustees with effect from October 2023. Cancer Research UK has announced the appointment of Lord Simon Stevens as Chair of Council of Trustees with effect from October 2023.

28 March 2023

• Health & Medicine

Our nurses answer your frequently asked questions about cancer

Our nurses have answered some of the frequently asked questions they hear on our Cancer Awareness Roadshow and at Cancer Awareness in the Workplace sessions. Our nurses have answered some of the frequently asked questions they hear on our Cancer Awareness Roadshow and at Cancer Awareness in the Workplace sessions.

2 March 2023

• Science & Technology

Hiding in plain sight: How we can use immune cells to deliver cancer-killing viruses to tumours

Researchers have found a way to deliver cancer-killing viruses to tumours by hiding them inside immune cells. Researchers have found a way to deliver cancer-killing viruses to tumours by hiding them inside immune cells.

9 February 2023

• Health & Medicine

Women in science: Cancer research pioneers – part 2

As our 20th anniversary year draws to a close, we’re celebrating some of the pioneering women who have contributed to impactful cancer research and paved the way for even more. As our 20th anniversary year draws to a close, we’re celebrating some of the pioneering women who have contributed to impactful cancer research and paved the way for even more.

25 January 2023

• Health & Medicine

Into the archives: the story of HPV and cervical cancer

From strengthening the understanding of the link between HPV and cervical cancer, to working towards reducing cervical cancer to the point where almost no one develops it, our history with this particular disease goes way back. From strengthening the understanding of the link between HPV and cervical cancer, to working towards reducing cervical cancer to the point where almost no one develops it, our history with this particular disease goes way back.

21 November 2022

• Health & Medicine

New study supports extending cervical screening intervals for people who test negative for HPV

A new study confirms that offering cervical screening using HPV testing effectively prevents cervical cancer without the need for as regular screening A new study confirms that offering cervical screening using HPV testing effectively prevents cervical cancer without the need for as regular screening

1 June 2022

• Health & Medicine

Immune cell count could determine whether chemotherapy is required in oropharyngeal cancer, new study finds 

A new study has found that the level of a person's immune cells may provide an indication of whether they would benefit from chemotherapy in oropharyngeal cancer. A new study has found that the level of a person's immune cells may provide an indication of whether they would benefit from chemotherapy in oropharyngeal cancer.

2 May 2022

• Opinion
• Health & Medicine

“That is what I dream”: India’s journey to rolling out the HPV vaccine

We spoke to Dr Ishu Kataria who works with WHO to prevent the spread of infections like HPV, which causes 99% of cervical cancers worldwide. We spoke to Dr Ishu Kataria who works with WHO to prevent the spread of infections like HPV, which causes 99% of cervical cancers worldwide.

17 November 2021

• Health & Medicine

“The power of science”: HPV vaccine proven to dramatically reduce cervical cancer

New results find that the HPV vaccine was shown to dramatically reduce cervical cancer rates by 90% in women in their 20s who were offered it at age 12 to 13. New results find that the HPV vaccine was shown to dramatically reduce cervical cancer rates by 90% in women in their 20s who were offered it at age 12 to 13.

3 November 2021